The Pfizer-backed cancer treatment developer, which initially floated in France in 2007, received $35m from Pfizer last year in return for a 10% stake.

Alzheimer's drug developer Heptares has been acquired by pharmaceutical company Sosei, providing exits to corporate backers Novartis and Takeda.

The Russian Government has announced a 10% cut to university spending following economic woes.

Cambridge spin-out Cambridge Chocolate Technologies unveils chocolate with anti-ageing properties.

Charity investor the Wellcome Trust appoints director of innovations.

Realm, an Australia-based startup driven by research from Teeside University, launches Kickstarter to bring physical world into computer games.